Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Enliven Therapeutics Inc’s current trading price is -31.87% away from its 52-week high, while its distance from the 52-week low is 87.70%. The stock’s price range over this period has fluctuated between $10.90 and $30.03. The company, operating within the financial sector, had a trading volume of approximately 0.5 million for the day, which was noticeably higher than the average daily share volume of 0.22 million over the last 3 months.
Enliven Therapeutics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $30.03 on 10/18/24, while the lowest value for the same period was recorded at $10.90 on 03/15/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Enliven Therapeutics Inc (ELVN) has experienced a quarterly decline of -26.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 999.66M and boasts a workforce of 46 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 24.84, with a change in price of -1.84. Similarly, Enliven Therapeutics Inc recorded 233,099 in trading volume during the last 100 days, posting a change of -8.25%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ELVN stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
ELVN Stock Stochastic Average
Today, Enliven Therapeutics Inc’s raw stochastic average for the past 50 days stands at 3.12%, indicating a decline from the raw stochastic average of the last 20 days, which was 5.76%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 10.80% and 30.51% respectively.
ELVN Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -9.07% this year. Over the last six months, there has been a stronger performance of -18.49%. The price of ELVN leaped by -15.03% during the last 30 days period. For the last 5-days stocks have slided -15.00%.
